← Back
Data updated: Jul 17, 2026
NIAGARA PHARMS
Pharma Pharmaceuticals
NIAGARA PHARMS is a pharmaceutical company with 1 FDA-approved products.
2011
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
NIAGARA PHARMS's Key Drugs
NIAGARA PHARMS's core commercial portfolio centers on PUR-WASH — its most strategically important drugs approved in the last 15 years.
NIAGARA PHARMS's Recent FDA Approvals
New NDA/BLA approvals for NIAGARA PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
NIAGARA PHARMS's Therapeutic Areas
Disease areas where NIAGARA PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
NIAGARA PHARMS Pipeline Snapshot
Active clinical trials for NIAGARA PHARMS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • PUR-WASH leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2011-09-01
- Latest
- 2026-02-02
- Applications
- 1